Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-22-024599)

Filing Details

Accession Number:: 0001127602-22-024599
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-11-01 16:30:40
Reporting Period:: 2022-10-28

Accepted Time:: 2022-11-01 16:30:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
310158	Merck & Co. Inc.	MRK	Pharmaceutical Preparations (2834)	221918501

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1916310	Jacobus Johannes Oosthuizen	Merck &Amp; Co., Inc. 126 Lincoln Avenue Rahway NJ 07065	President, U.s. Market	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-10-28	3,633	$100.21	10,881	No	4	S	Direct
Common Stock	Acquisiton	2022-10-30	913	$100.77	11,794	No	4	M	Direct
Common Stock	Disposition	2022-10-30	450	$100.77	11,344	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2022-10-30	913	$0.00	913	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
915	2021-10-30	2023-10-30	No	4	M	Direct

Footnotes

Holdings include shares acquired in dividend reinvestment transactions.
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2021, 10/30/2022 and 10/30/2023.